Sermorelin Drug Interactions and Contraindications

Sermorelin is a growth hormone–releasing hormone (GHRH) analog, and its drug interaction profile is fairly narrow because it is a peptide broken down by enzymes in the blood and tissues rather than by the liver's cytochrome P450 system. Most meaningful interactions involve other hormones and growth-hormone–related medications rather than everyday prescriptions like antibiotics or blood pressure pills. Sermorelin is not FDA-approved for general use in the United States, and the original brand product was discontinued, so it should only be used with medical supervision and regular lab monitoring.

Why Sermorelin Has Few Classic Drug Interactions

Most drug interactions happen when one medication changes how the liver processes another. Sermorelin largely sidesteps that pathway.

• It is a peptide. Sermorelin is degraded by peptidases, not CYP enzymes, so it rarely changes blood levels of other drugs.
• It acts on the pituitary. Sermorelin binds GHRH receptors and signals the pituitary to release the body's own growth hormone rather than adding growth hormone directly.
• The effect is self-limiting. Normal feedback loops involving somatostatin and IGF-1 still apply, so the response tends to plateau.

That said, few interactions is not the same as no interactions. Anything that raises or lowers growth hormone, IGF-1, blood sugar, or thyroid function can change how sermorelin behaves.

Drugs and Classes That May Interact With Sermorelin

This table is a starting point, not a complete list. Combining sermorelin with another hormone-active drug is a decision for a clinician who can track IGF-1, glucose, and thyroid labs.

Blood Sugar, Thyroid, and Hormone Medications

Diabetes drugs and glucose control

Growth hormone is a counter-regulatory hormone, meaning it pushes blood sugar upward. Sermorelin raises endogenous GH, so people using insulin or oral diabetes drugs may notice fasting glucose drifting. Because of that, reviewing semaglutide drug interactions before combining the two is a reasonable step, especially if weight loss is also a goal.

Thyroid hormone

Hypothyroidism blunts the pituitary's response to GHRH, so sermorelin may underperform in someone whose thyroid is not adequately treated. Growth hormone can also change how much thyroid hormone the body converts, which may mean levothyroxine doses need rechecking.

Testosterone, estrogen, and other hormones

Sex steroids shape the amplitude of natural GH pulses. Testosterone and estradiol generally increase them, so combining either with sermorelin can push IGF-1 higher than expected. Anyone already on growth hormone replacement should also review somatropin drug interactions, because recombinant hGH and sermorelin drive the same downstream signal.

Sermorelin Contraindications and Who Should Avoid It

When clinicians review sermorelin contraindications, they look for conditions where extra growth hormone or IGF-1 could be harmful. Common reasons to avoid it include:

• Active or recent cancer, especially tumors sensitive to IGF-1
• Pituitary tumors, hypothalamic disease, or another untreated pituitary disorder
• Pregnancy or breastfeeding
• Untreated hypothyroidism or uncontrolled diabetes
• Known hypersensitivity to sermorelin or related peptides
• Children with closed growth plates, since sermorelin offers no growth benefit after that point
• Active intracranial hypertension or proliferative diabetic retinopathy

These are general precautions, not a substitute for individual medical advice. A clinician who knows your history can tell you whether sermorelin is appropriate for you.

Timing, Food, and Drug Testing

Sermorelin is usually injected subcutaneously at night or early morning on an empty stomach, because eating, high blood sugar, and high free fatty acids all blunt growth hormone release. That is a timing issue rather than a drug interaction, but it affects real-world results as much as the medication list does.

Many people also ask does sermorelin show up on a drug test, and the answer depends on the test. Standard workplace urine panels do not screen for sermorelin or similar peptides, but anti-doping programs use growth hormone biomarkers and IGF-1 testing that can flag its use.

Half-life matters too. Unlike cjc-1295 without drug affinity complex, sermorelin is not modified to extend its time in circulation, so it is typically dosed daily rather than weekly.

Sermorelin vs. Other Peptides and What to Ask Your Doctor

If you are weighing sermorelin vs aod 9604, note that AOD-9604 is a modified fragment of human growth hormone studied for fat metabolism and does not trigger pituitary GH release the way sermorelin does. The two are not interchangeable, and their interaction profiles differ.

Before starting sermorelin, bring a complete medication and supplement list to your prescriber, including hormones, diabetes drugs, steroids, and thyroid medication. Ask which labs will be monitored, how often, and which symptoms should prompt a call. Any peptide that alters hormone signaling deserves that level of caution.